ISELIN, N.J., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for ...

Winter environmental conditions raise questions around eye cream formulation and the functional role of Manihot ...

First patients dosed in budoprutug PrisMN Phase 2 trial in pMN, with initial data expected second half 2026 Dosing ongoing in ...

Balance Sheet and Sharpened Strategy VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / January 8, 2026 / Lobe Sciences Ltd.

SAN DIEGO, CA / ACCESS Newswire / January 7, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or ...

This pharmaceutical composition, dosage form, and treatment method patent is part of a comprehensive IP portfolio covering naronapride, Renexxion's lead compound and a potential best-in-class, orally ...

VANCOUVER, British Columbia & GRAPEVINE, Texas, January 07, 2026--Alpha Cognition, Inc. (the "Company", "we", "us" and "ours") (NASDAQ: ACOG), a commercial-stage neuroscience company focused on ...

Shionogi plans to acquire global rights to Radicava and Radicava ORS for ALS through a new U.S. business formed by Tanabe ...

Balance Sheet and Sharpened Strategy VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / January 8, 2026 / Lobe Sciences Ltd. (CSE:LOBE)(OTCQB:LOBEF)(Frankfurt:LOBE.F) ("Lobe" or the "Company"), a biophar ...

Positioned as a dedicated Japanese Style Tempura Mix manufacturer, the organization provides a high-standard premix solution ...

Serán Bioscience, LLC,  in collaboration with leading developer and design-builder Mortenson, hosted a topping-out ceremony ...